🏆 MSInsight is a proud laureate of the PSCC BOOST Grant!

We’re honored to be selected among the 10 laureates of the first BOOST Grant cohort by the Paris Saclay Cancer Cluster (PSCC) 🎉

For MSInsight, this recognition is a strong signal of confidence in our mission: transforming Microsatellite Instability (MSI) testing into a universally accessible, reliable and standardized diagnostic to guide immunotherapy decisions for cancer patients worldwide.

This grant will help us accelerate the development and regulatory roadmap of MSIcare Cloud, our NGS-based MSI analysis platform. 🧬💻

A huge thank you to the PSCC team and the jury for their trust, and warm congratulations to our fellow laureates pushing the boundaries of oncology innovation: 👏 Abbelight • Letsee Imaging • @LiveRNA • One Biosciences • PEP-Therapy • Recobia Therapeutics • Skymab Biotherapeutics • @Spice Bio • TheraSonic

Press release https://lnkd.in/dP-w4BcJ